Iovanace Biotherapeutics (IOVA) PT Raised to $7 at UBS

August 20, 2026 6:03 AM

UBS analyst David Dai raised the price target on Iovanace Biotherapeutics (NASDAQ: IOVA) to $7.00 (from $4.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found